T. Clark Gamblin, MD, MS, MBA, The Stuart D. Wilson Chair in Surgical Oncology, joins Froedtert & The Medical College of Wisconsin from the University of Pittsburgh School of Medicine where he was Director of the University’s Neuroendocrine Cancer Treatment Center. Dr. Gamblin is an internationally known hepatobiliary surgeon whose clinical and research interests focus on primary and metastatic tumors of the liver. His research efforts include numerous clinical trials on the treatment of hepatocellular carcinoma, and National Institute health-supported basic science research involving liver cancer stem cells.
Dr. Gamblin serves as a reviewer for the Annals of Surgery, Annals of Surgical Oncology, Cancer and Journal of Clinical Oncology. He holds memberships in numerous professional and scientific societies. Dr. Gamblin has more than 120 peer reviewed publications and has authored multiple reviews and book chapters. He has presented more than 100 lectures on the multimodality management of liver tumors to regional, national and international audiences.
Diseases & Conditions
Treatment & Services
Education & Training
University of Mississippi School of Medicine - Jackson - Doctor of Medicine - (1998)
Mercer University School of Medicine - Macon - GA - Residency, General Surgery - (1998-2003)
University of Pittsburgh School of Medicine - PA - Fellowship, Surgical Oncology - (2003-2005)
University of Pittsburgh School of Medicine - PA - Master of Science - (2007)
Kellogg School of Management, Northwestern University - Evanston - IL - MBA - (2014-2015)
The comments are submitted by patients (or their caregivers) and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of the Froedtert & the Medical College of Wisconsin health network. Learn more about our survey.